Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 5/20 | 0.35 |
| ▸ | SAT1 | P21673 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18244899 | 0.88 | CYP2C19 (0.47) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL5932522 | 0.88 | ALDH1A1 (0.42) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL22330345 | 0.87 | TSHR (0.42) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL22050367 | 0.85 | CYP2C19 (0.36) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL7030276 | 0.83 | CYP2C19 (0.52) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL21920454 | 0.83 | TSHR (0.58) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL20807027 | 0.81 | ALDH1A1 (0.50) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL24166090 | 0.80 | ALDH1A1 (0.42) | MEN1KMT2ATSHRALDH1A1CYP3A4 | |
| SCHEMBL17308763 | 0.80 | TSHR (0.46) | CYP2C19MEN1GLAKMT2ATSHR | |
| SCHEMBL19860476 | 0.79 | CYP2C19 (0.48) | CYP2C19MEN1GLAKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3033113-B1 | A NOVEL PLGA-MODIFIED POLYETHYLENIMINE SELF-ASSEMBLY NANOTECHNOLOGY FOR NUCLEIC ACID AND DRUG DELIVERY | BAYLOR COLLEGE MEDICINE (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-3620456-B1 | COMPOUND WITH KINASE INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREOF | ZHANG FUYAO (CN) | 2021-11-17 | — | — | EP | disclosed |
| US-20180187022-A1 | SANITATION SYSTEMS AND COMPONENTS THEREOF HAVING A SLIPPERY SURFACE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2018-07-05 | — | — | US | disclosed |
| EP-2761011-B1 | USE OF NON-SUBTYPE B GAG PROTEINS FOR LENTIVIRAL PACKAGING | THERAVECTYS (FR) | 2018-05-23 | — | — | EP | disclosed |
| EP-1290002-A1 | CHEMICAL PRODUCTS SUITED FOR USE AS CO-CATALYSTS, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | Basell Polyolefine GmbH (DE) | 2003-03-12 | — | — | EP | disclosed |
| EP-1280600-A2 | SUPPORTED CATALYST SYSTEM COMPRISING A METALLOCENE, A LEWIS-BASE AND AN ORGANODEMENTAL COMPOUND OF MAIN GROUP III, AND ITS USE | Basell Polypropylen GmbH (DE) | 2003-02-05 | — | — | EP | disclosed |
| EP-1250363-A2 | CHEMICAL COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | Basell Polyolefine GmbH (DE) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001090112-A1 | CHEMICAL PRODUCTS SUITED FOR USE AS CO-CATALYSTS, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2001-11-29 | — | — | WO | disclosed |
| WO-2001047635-A2 | SUPPORTED CATALYST SYSTEM CONTAINING A METALLOCENE, A LEWIS BASE AND AN ELEMENTALLY ORGANIC COMPOUND OF MAIN GROUP III AND THE USE THEREOF | BASELL POLYPROPYLEN GMBH (DE) | 2001-07-05 | — | — | WO | disclosed |
| WO-2001048035-A2 | CHEMICAL COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2001-07-05 | — | — | WO | disclosed |